|
SGK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11669562485872E-11 |
| Normal-vs-Stage2 |
9.553700E-02 |
| Normal-vs-Stage3 |
9.78059999656722E-08 |
| Normal-vs-Stage4 |
2.33739999999649E-06 |
| Stage1-vs-Stage2 |
5.361900E-02 |
| Stage1-vs-Stage3 |
4.652600E-01 |
| Stage1-vs-Stage4 |
3.866200E-02 |
| Stage2-vs-Stage3 |
2.776500E-02 |
| Stage2-vs-Stage4 |
1.835980E-03 |
| Stage3-vs-Stage4 |
1.092610E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63324909152607E-12 |
| Normal-vs-AfricanAmerican |
2.313200E-01 |
| Normal-vs-Asian |
7.5678000000079E-05 |
| Caucasian-vs-AfricanAmerican |
7.895700E-02 |
| Caucasian-vs-Asian |
9.644000E-01 |
| AfricanAmerican-vs-Asian |
9.083900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51970999999751E-05 |
| Normal-vs-Female |
1.33226762955019E-15 |
| Male-vs-Female |
1.818030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.66360000722443E-09 |
| Normal-vs-Age(41-60Yrs) |
5.50470002913528E-10 |
| Normal-vs-Age(61-80Yrs) |
8.23970000000118E-05 |
| Normal-vs-Age(81-100Yrs) |
3.428400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.179000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.337400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.387400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.687000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.699800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.037400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.122330E-02 |
| Classical-VS-Follicular |
1.13809999979786E-07 |
| Classical-VS-Other |
1.596210E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.84262999999296E-05 |
| Tall-VS-Other |
2.351600E-02 |
| Tall-VS-Normal |
1.24180000005136E-06 |
| Follicular-VS-Other |
8.551000E-01 |
| Follicular-VS-Normal |
3.599800E-01 |
| Other-VS-Normal |
5.702000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00409999995266E-06 |
| Normal-vs-N1 |
8.48070000003531E-07 |
| N0-vs-N1 |
6.499700E-03 |
|
|
